Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas

Marco M. Altaras*, Rami Aviram, Ilan Cohen, Mario Cordoba, Shai Yarkoni, Yoram Beyth

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Abstract

We present the first case of heterologous mixed mesodermal tumor that developed 9 years following tamoxifen therapy in a climacteric woman with no previous pelvic irradiation and was initially treated by total abdominal hysterectomy and bilateral salpingo-oophorectomy. She continued tamoxifen therapy for 2 years, following the initial treatment, until the diagnosis of a recurrent tumor by laparotomy. The patient died of the disease 5 months subsequent to the second surgery. The association of prolonged unopposed estrogenic stimulation, with tamoxifen as a possible etiologic factor in the development of endometrial sarcomas, is discussed.

Original languageEnglish
Pages (from-to)255-258
Number of pages4
JournalGynecologic Oncology
Volume49
Issue number2
DOIs
StatePublished - May 1993
Externally publishedYes

Fingerprint

Dive into the research topics of 'Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas'. Together they form a unique fingerprint.

Cite this